Open access · US-GOV via ClinicalTrials.gov Clinical trial

Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study

Authors not listed

The Third Affiliated Hospital of Harbin Medical University · 2026

Stem-cell exhaustion Human Randomized controlled trial

Abstract

This is a multicenter, single-arm, exploratory clinical study designed to observe and evaluate the efficacy and safety of adebrelimab combined with oral etoposide for elderly patients and patients with poor performance status in small cell lung cancer.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-19 MST

Cite this

APA

Anonymous. (2026). Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study. <em>The Third Affiliated Hospital of Harbin Medical University</em>. https://clinicaltrials.gov/study/NCT07398560

Vancouver

Anonymous. Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study. The Third Affiliated Hospital of Harbin Medical University. 2026.

BibTeX

@misc{anon2026Adebre, title = {Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study}, author = {Anonymous}, journal = {The Third Affiliated Hospital of Harbin Medical University}, year = {2026}, }